Literature DB >> 28590505

Carotid endarterectomy for symptomatic carotid stenosis.

Saritphat Orrapin1, Kittipan Rerkasem.   

Abstract

BACKGROUND: Stroke is the third leading cause of death and the most common cause of long-term disability. Severe narrowing (stenosis) of the carotid artery is an important cause of stroke. Surgical treatment (carotid endarterectomy) may reduce the risk of stroke, but carries a risk of operative complications. This is an update of the Cochrane Review, originally published in 1999, and most recently updated in 2011.
OBJECTIVES: To determine the balance of benefit versus risk of endarterectomy plus best medical management compared with best medical management alone, in people with a recent symptomatic carotid stenosis (i.e. transient ischaemic attack (TIA) or non-disabling stroke). SEARCH
METHODS: We searched the Cochrane Stroke Group Trials Register (last searched in July 2016), CENTRAL (2016, Issue 7), MEDLINE (1966 to July 2016), Embase (1990 to July 2016), Web of Science Core Collection, ClinicalTrials.gov, WHO International Clinical Trials Registry Platform (ICTRP) portal, and handsearched relevant journals and reference lists. SELECTION CRITERIA: We included randomised controlled trials.   DATA COLLECTION AND ANALYSIS: Two review authors independently selected studies, assessed risk of bias, and extracted the data. MAIN
RESULTS: We included three trials involving 6343 participants. As the trials differed in the methods of measurement of carotid stenosis and in the definition of stroke, we did a pooled analysis of individual patient data on 6092 participants (35,000 patient years of follow-up), after reassessing the carotid angiograms and outcomes from all three trials using the primary electronic data files, and redefined outcome events where necessary, to achieve comparability.On re-analysis, there were no significant differences between the trials in the risks of any of the main outcomes in either of the treatment groups, or in the effects of surgery. Surgery increased the five-year risk of ipsilateral ischaemic stroke in participants with less than 30% stenosis (N = 1746, risk ratio (RR) 1.27, 95% confidence interval (CI) 0.80 to 2.01), had no significant effect in participants with 30% to 49% stenosis (N = 1429, RR 0.93, 95%CI 0.62 to 1.38), was of benefit in participants with 50% to 69% stenosis (N = 1549, RR 0.84, 95%CI 0.60 to 1.18), and was highly beneficial in participants with 70% to 99% stenosis without near-occlusion (N = 1095, RR 0.47, 95%CI 0.25 to 0.88). However, there was no evidence of benefit (N = 271, RR 1.03, 95%CI 0.57 to 1.84) in participants with near-occlusions. Ipsilateral ischaemic stroke describes insufficient blood flow to the cerebral hemisphere, secondary to same side severe stenosis of the internal carotid artery. AUTHORS'
CONCLUSIONS: Endarterectomy was of some benefit for participants with 50% to 69% symptomatic stenosis (moderate-quality evidence), and highly beneficial for those with 70% to 99% stenosis without near-occlusion (moderate-quality evidence). We found no benefit in people with carotid near-occlusion (high-quality evidence).

Entities:  

Mesh:

Year:  2017        PMID: 28590505      PMCID: PMC6481587          DOI: 10.1002/14651858.CD001081.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  59 in total

Review 1.  Epidemiology of stroke.

Authors:  R Bonita
Journal:  Lancet       Date:  1992-02-08       Impact factor: 79.321

2.  Importance of intracranial atherosclerotic disease in patients with symptomatic stenosis of the internal carotid artery. The North American Symptomatic Carotid Endarterectomy Trail.

Authors:  L J Kappelle; M Eliasziw; A J Fox; B L Sharpe; H J Barnett
Journal:  Stroke       Date:  1999-02       Impact factor: 7.914

3.  Endarterectomy for moderate symptomatic carotid stenosis: interim results from the MRC European Carotid Surgery Trial.

Authors: 
Journal:  Lancet       Date:  1996-06-08       Impact factor: 79.321

4.  Joint study of extracranial arterial occlusion. X. Internal carotid artery occlusion.

Authors:  W S Fields; N A Lemak
Journal:  JAMA       Date:  1976-06-21       Impact factor: 56.272

5.  Prognosis after transient monocular blindness associated with carotid-artery stenosis.

Authors:  O Benavente; M Eliasziw; J Y Streifler; A J Fox; H J Barnett; H Meldrum
Journal:  N Engl J Med       Date:  2001-10-11       Impact factor: 91.245

6.  Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours.

Authors:  C Fieschi; C Argentino; G L Lenzi; M L Sacchetti; D Toni; L Bozzao
Journal:  J Neurol Sci       Date:  1989-07       Impact factor: 3.181

7.  Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study.

Authors:  Lars Marquardt; Olivia C Geraghty; Ziyah Mehta; Peter M Rothwell
Journal:  Stroke       Date:  2009-11-19       Impact factor: 7.914

Review 8.  Status report on the North American symptomatic carotid surgery trial.

Authors:  H J Barnett
Journal:  J Mal Vasc       Date:  1993

9.  Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study.

Authors: 
Journal:  JAMA       Date:  1995-05-10       Impact factor: 56.272

Review 10.  Time trends in the published risks of stroke and death due to endarterectomy for symptomatic carotid stenosis.

Authors:  R Bond; K Rerkasem; C P Shearman; P M Rothwell
Journal:  Cerebrovasc Dis       Date:  2004-05-19       Impact factor: 2.762

View more
  33 in total

1.  Preventing stroke in symptomatic carotid artery disease during the COVID-19 pandemic.

Authors:  Joyce Hellegering; Maarten J van der Laan; Erik-Jan de Heide; Maarten Uyttenboogaart; Clark J Zeebregts; Reinoud P H Bokkers
Journal:  J Vasc Surg       Date:  2020-05-21       Impact factor: 4.268

2.  [Secondary stroke prevention after TIA or ischemic stroke].

Authors:  Hans Christoph Diener; Georg Nickenig
Journal:  Herz       Date:  2021-04-29       Impact factor: 1.443

Review 3.  [Important recommendations of the German-Austrian S3 guidelines on management of extracranial carotid artery stenosis].

Authors:  Hans-Henning Eckstein; Andreas Kühnl; Michael Kallmayer
Journal:  Chirurg       Date:  2022-03-22       Impact factor: 0.955

4.  Usefulness of rapid MR angiography using two-point Dixon for evaluating carotid and aortic plaques.

Authors:  Keisuke Morihara; Tatsu Nakano; Kentaro Mori; Issei Fukui; Motohiro Nomura; Keiichiro Suzuki; Kenichi Hirano; Mitsuyuki Takahashi; Hideyuki Takeuchi; Hiroshi Doi; Yoshihisa Kitamura; Fumiaki Tanaka
Journal:  Neuroradiology       Date:  2021-09-24       Impact factor: 2.804

5.  Contemporary Trends in Physician Utilization Rates of CEA and CAS for Asymptomatic Carotid Stenosis among Medicare Beneficiaries.

Authors:  Rebecca Sorber; Michael S Clemens; Peiqi Wang; Martin A Makary; Caitlin W Hicks
Journal:  Ann Vasc Surg       Date:  2020-09-03       Impact factor: 1.466

6.  A low-cost machine learning-based cardiovascular/stroke risk assessment system: integration of conventional factors with image phenotypes.

Authors:  Ankush Jamthikar; Deep Gupta; Narendra N Khanna; Luca Saba; Tadashi Araki; Klaudija Viskovic; Harman S Suri; Ajay Gupta; Sophie Mavrogeni; Monika Turk; John R Laird; Gyan Pareek; Martin Miner; Petros P Sfikakis; Athanasios Protogerou; George D Kitas; Vijay Viswanathan; Andrew Nicolaides; Deepak L Bhatt; Jasjit S Suri
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

7.  Diagnosis, Treatment and Follow-up in Extracranial Carotid Stenosis.

Authors:  Hans-Henning Eckstein; Andreas Kühnl; Joachim Berkefeld; Holger Lawall; Martin Storck; Dirk Sander
Journal:  Dtsch Arztebl Int       Date:  2020-11-20       Impact factor: 5.594

8.  Carotid Endarterectomy.

Authors:  Takayuki Hara; Yurie Rai
Journal:  Adv Tech Stand Neurosurg       Date:  2022

9.  The Use of Samsung Health and ECG M-Trace Base II Applications for the Assessment of Exercise Tolerance in the Secondary Prevention in Patients after Ischemic Stroke.

Authors:  Mateusz Lucki; Ewa Chlebuś; Agnieszka Wareńczak; Przemysław Lisiński
Journal:  Int J Environ Res Public Health       Date:  2021-05-27       Impact factor: 3.390

10.  Risk Factors for the Recurrence of CVD Incidents in Post-Stroke Patients over a 5-Year Follow-Up Period Based on the ICF Classification.

Authors:  Mateusz Lucki; Ewa Chlebuś; Agnieszka Wareńczak; Przemysław Lisiński
Journal:  Int J Environ Res Public Health       Date:  2021-06-03       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.